Biology Reference
In-Depth Information
[17] Casanova JL, Abel L, Quintana-Murci L. Human TLRs and IL-1Rs in host defense:
natural insights from evolutionary, epidemiological, and clinical genetics. Annu Rev
Immunol 2011;29:447-91.
[18] Blasius AL, Beutler B. Intracellular toll-like receptors. Immunity 2010;32(3):305-15.
[19] Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA
and activation of NF-kappaB by Toll-like receptor 3. Nature 2001;413(6857):732-8.
[20] Liu L, Botos I, Wang Y, et al. Structural basis of toll-like receptor 3 signaling with
double-stranded RNA. Science 2008;320(5874):379-81.
[21] Leonard JN, Ghirlando R, Askins J, et al. The TLR3 signaling complex forms by coopera-
tive receptor dimerization. Proc Natl Acad Sci U S A 2008;105(1):258-63.
[22] Bauernfeind F, Ablasser A, Kim S, Bartok E, Hornung V. An unexpected role for RNA in
the recognition of DNA by the innate immune system. RNA Biol 2010;7(2):151-7.
[23] Schulz O, Diebold SS, Chen M, et al. Toll-like receptor 3 promotes cross-priming to
virus-infected cells. Nature 2005;433(7028):887-92.
[24] Lee HK, Lund JM, Ramanathan B, Mizushima N, Iwasaki A. Autophagy-dependent viral
recognition by plasmacytoid dendritic cells. Science 2007;315(5817):1398-401.
[25] Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T. TICAM-1, an adaptor
molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.
Nat Immunol 2003;4(2):161-7.
[26] Matsumoto M, Oshiumi H, Seya T. Antiviral responses induced by the TLR3 pathway.
Rev Med Virol 2011;21(2):67-77.
[27] Sancho-Shimizu V, Perez de Diego R, Jouanguy E, Zhang SY, Casanova JL. Inborn errors
of anti-viral interferon immunity in humans. Curr Opin Virol 2011;1(6):487-96.
[28] Sancho-Shimizu V, Perez de Diego R, Lorenzo L, et al. Herpes simplex encephalitis
in children with autosomal recessive and dominant TRIF deficiency. J Clin Invest
2011;121(12):4889-902.
[29] Guo Y, Audry M, Ciancanelli M, et al. Herpes simplex virus encephalitis in a patient
with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity.
J Exp Med 2011;208(10):2083-98.
[30] Trumpfheller C, Caskey M, Nchinda G, et al. The microbial mimic poly IC induces
durable and protective CD4+ T cell immunity together with a dendritic cell targeted
vaccine. Proc Natl Acad Sci U S A 2008;105(7):2574-9.
[31] Kumar H, Koyama S, Ishii KJ, Kawai T, Akira S. Cutting edge: cooperation of IPS-1- and
TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T
cell responses. J Immunol 2008;180(2):683-7.
[32] von Herrath M. Diabetes: a virus-gene collaboration. Nature 2009;459(7246):518-9.
[33] Yu M, Levine SJ. Toll-like receptor, RIG-I-like receptors and the NLRP3 inflammasome:
key modulators of innate immune responses to double-stranded RNA viruses. Cytokine
Growth Factor Rev 2011;22(2):63-72.
[34] Yu M, Lam J, Rada B, Leto TL, Levine SJ. Double-stranded RNA induces shedding of the
34-kDa soluble TNFR1 from human airway epithelial cells via TLR3-TRIF-RIP1-depen-
dent signaling: roles for dual oxidase 2- and caspase-dependent pathways. J Immunol
2011;186(2):1180-8.
[35] Wang Y, Swiecki M, McCartney SA, Colonna M. dsRNA sensors and plasmacytoid den-
dritic cells in host defense and autoimmunity. Immunol Rev 2011;243(1):74-90.
[36] Sasai M, Linehan MM, Iwasaki A. Bifurcation of Toll-like receptor 9 signaling by adaptor
protein 3. Science 2010;329(5998):1530-4.
[37] Blasius AL, Arnold CN, Georgel P, et al. Slc15a4, AP-3, and Hermansky-Pudlak syn-
drome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic
cells. Proc Natl Acad Sci U S A 2010;107(46):19973-8.
[38] Subramanian S, Tus K, Li QZ, et al. A Tlr7 translocation accelerates systemic autoimmu-
nity in murine lupus. Proc Natl Acad Sci U S A 2006;103(26):9970-5.
[39] Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ. Toll-
like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflamma-
tory and regulatory roles in a murine model of lupus. Immunity 2006;25(3):417-28.
[40] Oh DY, Baumann K, Hamouda O, et al. A frequent functional toll-like receptor 7
polymorphism is associated with accelerated HIV-1 disease progression. AIDS
2009;23(3):297-307.
[41] Lee YH, Lee HS, Choi SJ, Ji JD, Song GG. Associations between TLR polymorphisms and
systemic lupus erythematosus: a systematic review and meta-analysis. Clin Exp Rheu-
matol 2012;30(2):262-5.
[42] Forsbach A, Nemorin JG, Montino C, et al. Identification of RNA sequence motifs
stimulating sequence-specific TLR8-dependent immune responses. J Immunol
2008;180(6):3729-38.
[43] Oh DY, Taube S, Hamouda O, et al. A functional toll-like receptor 8 variant is associated
with HIV disease restriction. J Infect Dis 2008;198(5):701-9.
442
Search WWH ::




Custom Search